500009 — Ambalal Sarabhai Enterprises Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for Ambalal Sarabhai Enterprises, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	R2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,636	1,967	1,703	1,736	1,962
Cost of Revenue
Gross Profit	630	811	665	715	807
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,651	1,863	1,615	1,683	1,991
Operating Profit	-14.5	104	87.9	52.9	-29.3
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	325	542	152	66.5	48.3
Provision for Income Taxes
Net Income After Taxes	294	472	114	56.8	49.3
Minority Interest
Net Income Before Extraordinary Items
Net Income	294	472	114	56.8	49.3
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	294	472	114	56.8	49.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.53	4.53	1.49	0.74	1.23